Dr. Lucas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of MichiganResidency, Pathology-Anatomic and Clinical, 1996 - 2001
Vanderbilt University School of MedicineClass of 1996
Vanderbilt UniversityPhD, 1992
Certifications & Licensure
MN State Medical License 2023 - 2025
PA State Medical License 2012 - 2024
MI State Medical License 1999 - 2015- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 677 citationsAdjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast CancerAndrew Tutt, Judy Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli
The New England Journal of Medicine. 2021-06-03 - 219 citationsAlpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions.Ming Zhou, Arul M. Chinnaiyan, Celina G. Kleer, Peter C. Lucas, Mark A. Rubin
The American Journal of Surgical Pathology. 2002-07-01 - 20 citationsPneumococcal Extracellular Vesicles Modulate Host Immunity.Saigopalakrishna S. Yerneni, Sarah Werner, Juliana Hofstatter Azambuja, Nils Ludwig, Rory Eutsey
Mbio. 2021-07-13
Press Mentions
How High Fat Foods Impact Diabetes and Metabolic SyndromeMay 22nd, 2012
Grant Support
- GPCR signaling through a novel NF-kB pathwayNational Heart, Lung, and Blood Institute (NHLBI)2013–2018
- Angiotensin II Signaling Through A Novel Nf-Kb PathwayNational Heart, Lung, And Blood Institute2008–2012
- Novel Signal Pathway Mediating Hypertension/Obesity-Dependent Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- A Novel Signaling Pathway Mediating Hypertension- And Obesity-Dependent Insulin RNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Nf-Kb Signaling &Molec Pathogenesis Of MALT LymphomaNational Cancer Institute2002–2006
- Ciper--A Novel Apoptosis Regulator Involved In CancerNational Cancer Institute2000–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
